Literature DB >> 1978514

The nigrostriatal system in Parkinson's disease.

A M Graybiel1, E C Hirsch, Y Agid.   

Abstract

Patterns of dopaminergic cell loss in the midbrain and patterns of mesostriatal fiber loss in the caudate nucleus and putamen are described for cases of idiopathic Parkinson's disease. Neither cell loss nor fiber loss is homogeneous. In the midbrain, quantitative analysis points to a selective vulnerability of neurons in the most heavily pigmented dopaminergic cell groups. In the striatum, a dorsolateral-to-ventromedial gradient of loss appears to characterize both the caudate nucleus and the putamen. These patterns of loss and sparing have implications both for analysis of the clinical symptoms of Parkinson's disease and for study of the etiology of this disease.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1978514

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  22 in total

Review 1.  Preservation of function in Parkinson's disease: what's learning got to do with it?

Authors:  Jeff A Beeler
Journal:  Brain Res       Date:  2011-09-29       Impact factor: 3.252

2.  Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.

Authors:  R Moratalla; B Quinn; L E DeLanney; I Irwin; J W Langston; A M Graybiel
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Preferential localization of self-stimulation sites in striosomes/patches in the rat striatum.

Authors:  N M White; N Hiroi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

4.  Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrils.

Authors:  Joseph R Patterson; Megan F Duffy; Christopher J Kemp; Jacob W Howe; Timothy J Collier; Anna C Stoll; Kathryn M Miller; Pooja Patel; Nathan Levine; Darren J Moore; Kelvin C Luk; Sheila M Fleming; Nicholas M Kanaan; Katrina L Paumier; Omar M A El-Agnaf; Caryl E Sortwell
Journal:  Neurobiol Dis       Date:  2019-07-02       Impact factor: 5.996

5.  Striosomal arrangement of met-enkephalin and substance P expression in parkinsonism-dementia complex on Guam.

Authors:  H Ito; S Goto; S Sakamoto; A Hirano
Journal:  Acta Neuropathol       Date:  1993       Impact factor: 17.088

6.  Estrogen, testosterone, and sequential movement in men.

Authors:  Jessica A Siegel; Laura A Young; Michelle B Neiss; Mary H Samuels; Charles E Roselli; Jeri S Janowsky
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

7.  Transduction of brain dopamine neurons by adenoviral vectors is modulated by CAR expression: rationale for tropism modified vectors in PD gene therapy.

Authors:  Travis B Lewis; Joel N Glasgow; Anya M Glandon; David T Curiel; David G Standaert
Journal:  PLoS One       Date:  2010-09-17       Impact factor: 3.240

8.  Dopamine regulates phosphorylation of VEGF receptor 2 by engaging Src-homology-2-domain-containing protein tyrosine phosphatase 2.

Authors:  Sutapa Sinha; Pawan Kumar Vohra; Resham Bhattacharya; Shamit Dutta; Shirshendu Sinha; Debabrata Mukhopadhyay
Journal:  J Cell Sci       Date:  2009-08-25       Impact factor: 5.285

9.  Simultaneous [99mTc]TRODAT-1 and [123I]ADAM brain SPECT in nonhuman primates.

Authors:  Kuo-Hsing Ma; Jong-Kang Lee; San-Yuan Huang; Chin-Bin Yeh; Yi-Chun Shen; Lie-Hang Shen; Chia-Chieh Chen; Ren-Shyan Liu; Jiang-Chuan Liu; Wen-Sheng Huang
Journal:  Mol Imaging Biol       Date:  2009-02-19       Impact factor: 3.488

Review 10.  An update on the connections of the ventral mesencephalic dopaminergic complex.

Authors:  L Yetnikoff; H N Lavezzi; R A Reichard; D S Zahm
Journal:  Neuroscience       Date:  2014-04-13       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.